Greenberg Traurig
Greenberg Traurig shareholders Bob Grossman and Josh Samek, along with ex-partner Ira Rosner (now with Holland & Knight), led an 11-attorney team that guided OPKO Health Inc. in its $1.47 billion acquisition in August 2015 of Bio-Reference Laboratories, one of the largest and fastest growing full service diagnostic laboratory companies on the globe. In the all-stock deal, Bio-Reference shareholders received 2.75 shares of OPKO common stock for each share of Bio-Reference common stock. Both firms are publicly traded.
